Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative review
Maria Gabriella Matera, Paola Rogliani, Luigino Calzetta, et al.
Respiratory Medicine (2020) Vol. 171, pp. 106114-106114
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

COVID-19 drugs in aquatic systems: a review
Willis Gwenzi, Rangabhashiyam Selvasembian, Nnanake‐Abasi O. Offiong, et al.
Environmental Chemistry Letters (2022) Vol. 20, Iss. 2, pp. 1275-1294
Open Access | Times Cited: 77
COVID-19-associated acute respiratory distress syndrome (CARDS): Current knowledge on pathophysiology and ICU treatment – A narrative review
Carmen A. Pfortmueller, Thibaud Spinetti, Richard D. Urman, et al.
Best Practice & Research Clinical Anaesthesiology (2020) Vol. 35, Iss. 3, pp. 351-368
Open Access | Times Cited: 97
Temporal trends in severe COVID-19 outcomes in patients with rheumatic disease: a cohort study
April Jorge, Kristin M. D’Silva, A. N. Cohen, et al.
The Lancet Rheumatology (2020) Vol. 3, Iss. 2, pp. e131-e137
Open Access | Times Cited: 70
Controversy surrounding the Sputnik V vaccine
Mario Cazzola, Paola Rogliani, Filomena Mazzeo, et al.
Respiratory Medicine (2021) Vol. 187, pp. 106569-106569
Open Access | Times Cited: 60
The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19
Shengguang Wang, Zhen Li, Xinyu Wang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 44
Therapeutic potential of proteases in acute lung injury and respiratory distress syndrome via TLR4/Nrf2/NF-kB signaling modulation
Hend Mohamed Anwar, Gad Elsayed Mohamed Salem, Hanan M. Abd El-Latief, et al.
International Journal of Biological Macromolecules (2024) Vol. 267, pp. 131153-131153
Closed Access | Times Cited: 4
Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury
Francesco Cattel, Susanna Giordano, Cecilia Bertiond, et al.
Respiratory Physiology & Neurobiology (2021) Vol. 288, pp. 103645-103645
Open Access | Times Cited: 31
Corticosteroids for COVID-19: worth it or not?
F. Akter, Yusha Araf, Mohammad Jakir Hosen
Molecular Biology Reports (2021) Vol. 49, Iss. 1, pp. 567-576
Open Access | Times Cited: 31
Use of Thiols in the Treatment of COVID-19: Current Evidence
Mario Cazzola, Paola Rogliani, Sundeep Salvi, et al.
Lung (2021) Vol. 199, Iss. 4, pp. 335-343
Open Access | Times Cited: 28
Outcomes of acute respiratory distress syndrome in COVID-19 patients compared to the general population: a systematic review and meta-analysis
Adam A. Dmytriw, Richa Chibbar, Petty Pin Yu Chen, et al.
Expert Review of Respiratory Medicine (2021) Vol. 15, Iss. 10, pp. 1347-1354
Open Access | Times Cited: 23
Co-aerosolized Pulmonary Surfactant and Ambroxol for COVID-19 ARDS Intervention: What Are We Waiting for?
Pradeep Kumar
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 25
Repurposing Fostamatinib to Combat SARS-CoV-2-Induced Acute Lung Injury
Neha Tabassum, Hua Zhang, Justin Stebbing
Cell Reports Medicine (2020) Vol. 1, Iss. 8, pp. 100145-100145
Open Access | Times Cited: 17
Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients
Adrian Krygier, Dagmara Szmajda‐Krygier, Rafał Świechowski, et al.
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1845-1845
Open Access | Times Cited: 10
Worsening of heart failure by coronavirus disease 2019 is associated with high mortality
Edimar Alcides Bocchi, Ivna Girard Cunha Vieira Lima, Bruno Biselli, et al.
ESC Heart Failure (2021) Vol. 8, Iss. 2, pp. 943-952
Open Access | Times Cited: 13
TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial
Lorraine B. Ware, Nima Soleymanlou, Daniel F. McAuley, et al.
Thorax (2023) Vol. 78, Iss. 8, pp. 816-824
Open Access | Times Cited: 5
SARS-CoV-2 and Influenza Co-Infection: Fair Competition or Sinister Combination?
Teluguakula Narasaraju, Vincent Chow, Pandareesh MD, et al.
(2024)
Open Access | Times Cited: 1
Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study
Saja Almazrou, Ziyad S. Almalki, Abdullah Salah Alanazi, et al.
Saudi Pharmaceutical Journal (2020) Vol. 28, Iss. 12, pp. 1877-1882
Open Access | Times Cited: 12
COVID-19-Associated acute respiratory distress syndrome (CARDS): Mechanistic insights on therapeutic intervention and emerging trends
Komal Thapa, Nitin Verma, Thakur Gurjeet Singh, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108328-108328
Open Access | Times Cited: 10
Healthcare resource use and associated costs in a cohort of hospitalized COVID-19 patients in Spain: A retrospective analysis from the first to the third pandemic wave. EPICOV study
Georgina Drago, Francisco Javier Pérez‐Sádaba, Susana Aceituno, et al.
PLoS ONE (2023) Vol. 18, Iss. 1, pp. e0280940-e0280940
Open Access | Times Cited: 3
Clinical Outcomes and Severity of Acute Respiratory Distress Syndrome in 1154 COVID-19 Patients: An Experience Multicenter Retrospective Cohort Study
Abbas Al Mutair, Saad Alhumaid, Laila Layqah, et al.
COVID (2022) Vol. 2, Iss. 8, pp. 1102-1115
Open Access | Times Cited: 5
Methylene blue for COVID-19 ARDS: insights from a randomized Clinical Trial
Zahra Sadat Sanei, Fatemeh Shahrahmani, Behrooz Khaleghi Manesh, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
ASSOCIATION BETWEEN ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) INCIDENCE AND INCREASED D-DIMER IN COVID-19 PATIENTS AT BETHESDA HOSPITAL YOGYAKARTA
Frans Iqlessias Hutagaol, Wiwiek Probowati, Widya Christine Manus
Berkala Ilmiah Kedokteran Duta Wacana (2024) Vol. 9, Iss. 1
Open Access
COVID‐19 acute respiratory distress syndrome: intriguing haemodynamics of an intriguing syndrome
Nick Smith, Emmanouil Tampakakis
European Journal of Heart Failure (2020) Vol. 23, Iss. 2, pp. 208-210
Open Access | Times Cited: 3
COVID-19 and the ageing immune system in an elderly patient : a case report
I Gusti Putu Suka Aryana, Ida Ayu Pradnya Paramita
Universa Medicina (2023) Vol. 42, Iss. 1, pp. 101-107
Open Access | Times Cited: 1
COVID-19 Hastalarında Akut Solunum Sıkıntısı Sendromu Yönetimi
Pınar Karabacak, Pakize Kırdemir
SDÜ Tıp Fakültesi Dergisi (2021) Vol. 28, Iss. COVİD-19 ÖZEL SAYI, pp. 51-56
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top